ANGO

AngioDynamics, Inc. (NASDAQ:ANGO) is a medical device company founded in 1988 and headquartered in Latham, New York. The company designs, manufactures, and sells specialized medical devices used by healthcare professionals for treating peripheral vascular disease, providing vascular access, and performing oncology and surgical procedures. Since going public in 2004, AngioDynamics has been transforming from a traditional medical device manufacturer into a focused medical technology company, concentrating on high-growth therapeutic areas including minimally invasive cancer treatment and advanced vascular interventions.